PATENT CLAIM ANALYSIS

Application Number: 15909112
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Disclosed are yeast-based immunotherapeutic compositions, hepatitis B virus (HBV) antigens, and fusion proteins for the treatment and/or prevention of HBV infection and symptoms thereof, as well as methods of using the yeast-based immunotherapeutic compositions, HBV antigens, and fusion proteins for the prophylactic and/or therapeutic treatment of HBV and/or symptoms thereof.

Claim (Index 74):
The method of  claim 72 , wherein the immunotherapeutic composition comprises:\n a) a yeast comprising a fusion protein; and b) the fusion protein comprising an amino acid sequence that is at least 95% identical to SEQ ID NO:92.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 90.0
- Lexical Diversity: 1.8125
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14184481', '15212930', '13798837', '13984888', '14494235']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8319134027959483
- 35 USC 102 Novelty (BERT): 0.6332052384059246
- Combined Prediction Score: 0.8120425863569459
- Mean Citation Score: 702.23269
- Max Citation Score: 711.39355
- Similarity Product: 524.9413420665652

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test